Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 2
Submit an article Journal homepage
2,638
Views
42
CrossRef citations to date
0
Altmetric
Original Research

DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients

Asma A. ElashiCancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, QatarView further author information
,
Varun Sasidharan NairCancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, QatarView further author information
,
Rowaida Z. TahaCancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, QatarView further author information
,
Hibah ShaathCancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, QatarView further author information
&
Eyad ElkordCancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar;Institute of Cancer Sciences, University of Manchester, Manchester, UKCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3868-0318View further author information
ORCID Icon
Article: e1542918 | Received 25 Jul 2018, Accepted 25 Oct 2018, Published online: 10 Nov 2018

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Reem Saleh, Salman M. Toor, Rowaida Z. Taha, Dana Al-Ali, Varun Sasidharan Nair & Eyad Elkord. (2020) DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR– myeloid cells, compared with HLA-DR+ antigen-presenting cells. Epigenetics 15:12, pages 1275-1288.
Read now

Articles from other publishers (41)

Jinghan Yang, Liang Qiu, Xi Wang, Xi Chen, Pingdong Cao, Zhe Yang & Qiang Wen. (2023) Liquid biopsy biomarkers to guide immunotherapy in breast cancer. Frontiers in Immunology 14.
Crossref
Bi Meng, Xuan Zhao, Shuchang Jiang, Zijian Xu, Sijin Li, Xu Wang, Wen Ma, Liantao Li, Dan Liu, Junnian Zheng, Hui Peng & Ming Shi. (2023) AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses. Frontiers in Immunology 14.
Crossref
A-Reum Nam, Min Heo, Kang-Hoon Lee, Ji-Yoon Kim, Sung-Ho Won & Je-Yoel Cho. (2023) The landscape of PBMC methylome in canine mammary tumors reveals the epigenetic regulation of immune marker genes and its potential application in predicting tumor malignancy. BMC Genomics 24:1.
Crossref
Huizeng Wang, Bingchun Liu, Hong Chen, Peixin Xu, Huiting Xue & Jianlong Yuan. (2023) Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer. Genes and Environment 45:1.
Crossref
Irina Gilyazova, Kadriia Enikeeva, Guzel Rafikova, Evelina Kagirova, Yuliya Sharifyanova, Dilara Asadullina & Valentin Pavlov. (2023) Epigenetic and Immunological Features of Bladder Cancer. International Journal of Molecular Sciences 24:12, pages 9854.
Crossref
Chenming Guo, Zhiwen Luo, Dilimulati Ismtula, Xiaojuan Bi, Han Kong, Yiyang Wang, Zhen Yang & Xinmin Mao. (2023) TIGIT as a Novel Prognostic Marker for Immune Infiltration in Invasive Breast Cancer. Combinatorial Chemistry & High Throughput Screening 26:3, pages 639-651.
Crossref
Fan Bu, Yeping Zhang, Ning Zhao, Xiaoai Tian & Yirong Xu. (2023) Ezrin regulates the progression of NSCLC by YAP and PD-L1. Clinical and Translational Oncology 25:7, pages 2239-2249.
Crossref
Handi CaoSanxing GaoRitika JoganiRyohichi Sugimura. (2022) The Tumor Microenvironment Reprograms Immune Cells. Cellular Reprogramming 24:6, pages 343-352.
Crossref
Baran Mollavelioglu, Esin Cetin Aktas, Neslihan Cabioglu, Aykhan Abbasov, Semen Onder, Selman Emiroglu, Mustafa Tükenmez, Mahmut Muslumanoglu, Abdullah Igci, Gunnur Deniz & Vahit Ozmen. (2022) High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer. World Journal of Surgical Oncology 20:1.
Crossref
Xiaoran Ma, Jibiao Wu, Bin Wang, Cun Liu, Lijuan Liu & Changgang Sun. (2022) Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review). International Journal of Oncology 61:5.
Crossref
Sonia Aristin Revilla, Onno Kranenburg & Paul J. Coffer. (2022) Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting. Frontiers in Immunology 13.
Crossref
Lishu ZhaoHao WangKandi XuXinyue LiuYayi He. (2022) Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications. Chinese Medical Journal 135:10, pages 1203-1212.
Crossref
Tiziana Annese, Roberto Tamma & Domenico Ribatti. (2022) Update in TIGIT Immune-Checkpoint Role in Cancer. Frontiers in Oncology 12.
Crossref
Ching-Ann Liu, Wei-Hsiu Liu, Hsin-I Ma, Yuan-Hao Chen, Dueng-Yuan Hueng, Wen-Chiuan Tsai, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou, Jen-Wei Liu, Jui-Hao Lee & Tsung-Lang Chiu. (2022) Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance. Cancers 14:4, pages 1051.
Crossref
Yingying Liang & Sevin Turcan. (2022) Epigenetic Drugs and Their Immune Modulating Potential in Cancers. Biomedicines 10:2, pages 211.
Crossref
Pooya Farhangnia & Mahzad Akbarpour. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 206 220 .
Fangdie Ye, Yingchun Liang, Jimeng Hu, Yun Hu, Yufei Liu, Zhang Cheng, Yuxi Ou, Chenyang Xu & Haowen Jiang. (2021) DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Thilona Arumugam, Upasana Ramphal, Theolan Adimulam, Romona Chinniah & Veron Ramsuran. (2021) Deciphering DNA Methylation in HIV Infection. Frontiers in Immunology 12.
Crossref
Yuanyuan Zhang, Lei zhang, Hongru Sun, Ying Liu, Jing Xu, Hao Huang, Jinming Fu, Ding Zhang, Tian Tian, Yashuang Zhao & Guiyu Wang. (2021) Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer. Molecular Medicine 27:1.
Crossref
Christophe Glorieux, Xiaojun Xia & Peng Huang. (2021) The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer. Cancers 13:17, pages 4426.
Crossref
Yizi Cong, Jing Liu, Gang Chen & Guangdong Qiao. (2021) The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy. Frontiers in Oncology 11.
Crossref
Magdalena Piotrowska, Mateusz Gliwiński, Piotr Trzonkowski & Dorota Iwaszkiewicz-Grzes. (2021) Regulatory T Cells-Related Genes Are under DNA Methylation Influence. International Journal of Molecular Sciences 22:13, pages 7144.
Crossref
Semir Vranic, Farhan S. Cyprian, Zoran Gatalica & Juan Palazzo. (2021) PD-L1 status in breast cancer: Current view and perspectives. Seminars in Cancer Biology 72, pages 146-154.
Crossref
Mobina Jalalvand, Farzaneh Darbeheshti & Nima Rezaei. (2021) Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer. Immunotherapy 13:7, pages 587-603.
Crossref
Yunkai Yang & Yan Wang. (2021) Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment. Frontiers in Immunology 12.
Crossref
S. Hua, M. Gu, Y. Wang, D. Ban & H. Ji. (2020) Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells. Clinical and Translational Oncology 23:4, pages 750-756.
Crossref
Sofia Batalha, Sofia Ferreira & Catarina Brito. (2021) The Peripheral Immune Landscape of Breast Cancer: Clinical Findings and In Vitro Models for Biomarker Discovery. Cancers 13:6, pages 1305.
Crossref
Karthik Dhatchinamoorthy, Jeff D. Colbert & Kenneth L. Rock. (2021) Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Frontiers in Immunology 12.
Crossref
Xirong Lu, Yuyi Li, Wei Yang, Minghao Tao, Yanmiao Dai, Jinkang Xu & Qianfei Xu. (2020) Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells. Journal of Biochemical and Molecular Toxicology 35:1.
Crossref
Feng Xu, Lulu He, Xueqin Zhan, Jiexin Chen, Huan Xu, Xiaoling Huang, Yangyi Li, Xiaohe Zheng, Ling Lin & Yongsong Chen. (2020) DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications. Aging 12:24, pages 25275-25293.
Crossref
Borja Bandera-Merchan, Hatim Boughanem, Ana B. Crujeiras, Manuel Macias-Gonzalez & Francisco J. Tinahones. (2020) Ketotherapy as an epigenetic modifier in cancer. Reviews in Endocrine and Metabolic Disorders 21:4, pages 509-519.
Crossref
Varun Sasidharan Nair, Reem Saleh, Salman M Toor, Rowaida Z Taha, Ayman A Ahmed, Mohamed A Kurer, Khaled Murshed, Mohamed Abu Nada & Eyad Elkord. (2020) Epigenetic regulation of immune checkpoints and T cell exhaustion markers in tumor-infiltrating T cells of colorectal cancer patients. Epigenomics 12:21, pages 1871-1882.
Crossref
Salman M. Toor, Varun Sasidharan Nair, Julie Decock & Eyad Elkord. (2020) Immune checkpoints in the tumor microenvironment. Seminars in Cancer Biology 65, pages 1-12.
Crossref
Reem Saleh, Rowaida Z. Taha, Salman M. Toor, Varun Sasidharan Nair, Khaled Murshed, Mahwish Khawar, Mahmood Al-Dhaheri, Mahir Abdulla Petkar, Mohamed Abu Nada & Eyad Elkord. (2020) Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer. Cancer Immunology, Immunotherapy 69:10, pages 1989-1999.
Crossref
Anne Fröhlich, Judith Sirokay, Simon Fietz, Timo J. Vogt, Jörn Dietrich, Romina Zarbl, Mike Florin, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Lukas Flatz, Sandra S. Ring, Carsten Golletz, Torsten Pietsch, Sebastian Strieth, Peter Brossart, Gerrit H. Gielen, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg & Dimo Dietrich. (2020) Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. eBioMedicine 59, pages 102962.
Crossref
Esther Schwich, Gia-Gia T. Hò, Joel LeMaoult, Christina Bade-Döding, Edgardo D. Carosella, Peter A. Horn & Vera Rebmann. (2020) Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary. Frontiers in Immunology 11.
Crossref
Dan Zhao, Isa Mambetsariev, Haiqing Li, Chen Chen, Jeremy Fricke, Patricia Fann, Prakash Kulkarni, Yan Xing, Peter P. Lee, Andrea Bild, Erminia Massarelli, Marianna Koczywas, Karen Reckamp & Ravi Salgia. (2020) Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors. Lung Cancer 146, pages 174-181.
Crossref
Reem Saleh, Salman M. Toor, Varun Sasidharan Nair & Eyad Elkord. (2020) Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression. Frontiers in Immunology 11.
Crossref
Corinna Keup, Rainer Kimmig & Sabine Kasimir-Bauer. (2020) Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies. Breast Care 15:5, pages 470-480.
Crossref
Mohammad A. I. Al-Hatamleh, Engku Nur Syafirah E.A.R., Jennifer C. Boer, Khalid Ferji, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski & Rohimah Mohamud. (2019) Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment. Cells 9:1, pages 33.
Crossref
Cinzia Solinas, Edoardo Migliori, Pushpamali De Silva & Karen Willard-Gallo. (2019) LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer. Cancers 11:8, pages 1213.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.